Celesta Capital — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Biomason uses biotechnology to grow biocement, producing concrete and tile products by using bacteria to bind natural materials as an alternative to Portland cement, aimed at concrete producers and the construction industry.
BiotechClimate TechConstruction TechNew MaterialsResearch Triangle Park, US
Ginger K. Dosier(Executive Officer, Director)Michael F. Noel(Director)John M. Dosier(Executive Officer)
Board seatMichael Marks· per SEC Form D
Co-investorsNovo HoldingsCarbonCelesta Capital
Percipient combines computer vision and AI technology to address national security and defense applications.
AI & Machine LearningData & InfrastructureDeep TechDefense TechSanta Clara, US
Balan Ayyar(Founder & CEO, Brig Gen (USAF, Ret.))inRaj Shah(Co-Founder & Chief Product Officer)in
Board seatMichael Marks· per SEC Form D
Co-investorsAlleyCorpCelesta CapitalVenrockAlley Robotics VenturesValor Equity Partners
TagoreTech is a fabless semiconductor company developing GaN and GaAs RF and power management products, including GaN-on-Silicon devices, for applications such as military and public safety communications, radar, drones, jammers, and 5G cellular infrastructure.
Deep TechHardwareSemiconductorsArlington Heights, US
Manish Shah(Co-founder & Chief Technology Officer)Paul Hart(Executive Management (RF semiconductor))Klaus Buehring(Chief Marketing Officer)
BoardAndrew Kau(Director)Oleg Khaykin(Director)
Co-investorsCelesta Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.